Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA)

Journal Article · · Endocrinology; (United States)
OSTI ID:5579229
Previous measurements of somatomedins (Sms) and insulin-like growth factors (IGFs) in maternal and fetal serum have yielded contradictory results. We have, therefore, measured maternal, fetal, and neonatal rat serum with two highly specific assays: 1) IGF-I/Sm-C RIA and 2) a highly specific IGF-II/rat placental membrane radioreceptor assay (RRA). In addition, we have made measurements with a less specific multiplication-stimulating activity (MSA)-rat placental membrane RRA. To avoid possible serious artifacts created by Sm-binding proteins, preliminary acid-ethanol extraction of serum was performed. Results are expressed in terms of a reference human serum with an assigned potency of 1 U/ml. We now conclude that radioimmunoassayable IGF-I is present in higher concentrations than previously reported interm fetal rat serum and that radioreceptor assayable IGF-II is selectively elevated in rat fatal and neonatal life and may have unique metabolic and rowth-promoting significance.
Research Organization:
Washington University School of Medicine, St. Louis, MO
OSTI ID:
5579229
Journal Information:
Endocrinology; (United States), Journal Name: Endocrinology; (United States) Vol. 110:2; ISSN ENDOA
Country of Publication:
United States
Language:
English